Form 4: Nutex Health COO Joshua DeTillio Increases Stake in Company

Nutex Health's Chief Operating Officer, Joshua DeTillio, recently purchased additional shares of the company's common stock.

Summary

• On August 19, 2024, Joshua DeTillio, the Chief Operating Officer of Nutex Health, Inc., acquired 1,300 shares of common stock at a price of $17.85 per share.
• Following this transaction, Mr. DeTillio directly held 4,233 shares.
• On August 20, 2024, Mr. DeTillio acquired an additional 575 shares of common stock at a price of $17.40 per share.
• Following this transaction, Mr. DeTillio directly held 4,808 shares.
• The shares are held in an account with his spouse as joint tenants with rights of survivorship.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as insider buying often signals confidence in the company's prospects. However, the purchase is relatively small.

Positives

• The COO's purchase of additional shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company insider believes the company's stock is undervalued or that the company will perform well in the future.

Stakeholder Impact

• The stock purchase could positively influence shareholder sentiment.

Key Dates